Volcano Announces Placement of 1,000th s5 and s5i IVUS Imag...(he company's success and timing of produ...)

Date:5/12/2008

he company's success and timing of product development and new product introductions, including the installations of the Volcano imaging systems, the expected performance of its products and product enhancements, the integration of our products into new or existing cath labs, and market penetration, conditions and expectations. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's annual report on Form 10-K, quarterly report on Form 10-Q, and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

'/>"/>

SOURCE Volcano Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
2. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
3. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
4. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
5. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
6. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
7. Volcano Announces Closing of CardioSpectra Acquisition
8. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
9. Volcano Corporation Announces Pricing of Common Stock Offering
10. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
11. NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect